Caffeic Acid Tablets as a Second-line Therapy for ITP
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The investigators are undertaking a multicentre, randomised controlled trial of 120 adults
with newly diagnosed ITP from 5 medical centers in China. Part of the participants are
randomly selected to receive caffeic acid tablets combining dexamethasone and the other part
are selected to receive high-dose dexamethasone treatment. Platelet count, bleeding and other
symptoms were evaluated before and after treatment. Adverse events are also recorded
throughout the study.
Phase:
Phase 3
Details
Lead Sponsor:
Shandong University
Collaborators:
Anhui Medical University Qianfoshan Hospital Qingdao University Shandong Provincial Hospital